These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6165264)

  • 1. Cellular interactions in the augmentation of human NK activity by interferon.
    Saksela E; Timonen T; Cantell K
    Ann N Y Acad Sci; 1980; 350():102-11. PubMed ID: 6165264
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of interferon in regulation of cytotoxicity by natural killer cells and macrophages.
    Herberman RB; Ortaldo JR; Djeu JY; Holden HT; Jett J; Lang NP; Rubinstein M; Pestka S
    Ann N Y Acad Sci; 1980; 350():63-71. PubMed ID: 6165306
    [No Abstract]   [Full Text] [Related]  

  • 3. Interferon modulation of natural killer cell activity.
    Perussia B; Santoli D; Trinchieri G
    Ann N Y Acad Sci; 1980; 350():55-62. PubMed ID: 6165304
    [No Abstract]   [Full Text] [Related]  

  • 4. Dual mechanism of interferon augmentation of natural killer cytotoxicity (NKCC).
    Targan S; Dorey F
    Ann N Y Acad Sci; 1980; 350():121-9. PubMed ID: 6165267
    [No Abstract]   [Full Text] [Related]  

  • 5. Augmentation by interferon of human natural and antibody-dependent cell-mediated cytotoxicity.
    Herberman RR; Ortaldo JR; Bonnard GD
    Nature; 1979 Jan; 277(5693):221-3. PubMed ID: 95205
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of interferon in augmentation of natural and antibody-dependent cell-mediated cytotoxicity.
    Herberman RB; Djeu JY; Ortaldo JR; Holden HT; West WH; Bonnard GD
    Cancer Treat Rep; 1978 Nov; 62(11):1893-6. PubMed ID: 728907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro interactions of purified cloned human interferons on NK cells: enhanced activation.
    Targan S; Stebbing N
    J Immunol; 1982 Sep; 129(3):934-5. PubMed ID: 6180004
    [No Abstract]   [Full Text] [Related]  

  • 8. Metabolic requirements for the in vitro augmentation of mouse natural killer activity by interferon.
    Djeu JY; Stocks N; Varesio L; Holden HT; Herberman RB
    Cell Immunol; 1981 Feb; 58(1):49-60. PubMed ID: 6164493
    [No Abstract]   [Full Text] [Related]  

  • 9. Natural killer cells.
    Kimber I
    Med Lab Sci; 1985 Jan; 42(1):60-77. PubMed ID: 2580211
    [No Abstract]   [Full Text] [Related]  

  • 10. Interferon, NK cells and persistent virus infection.
    Minato N; Reid L; Neighbour A; Bloom BR; Holland J
    Ann N Y Acad Sci; 1980; 350():42-52. PubMed ID: 6165292
    [No Abstract]   [Full Text] [Related]  

  • 11. Enhancement of mouse NK cells by interferon.
    Senik A; Gresser I; Maury C; Gidlund M; Orn A; Wigzell H
    Transplant Proc; 1979 Mar; 11(1):993-6. PubMed ID: 452109
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of chloroquine, mefloquine and quinine on natural killer cell activity in vitro. An analysis of the inhibitory mechanism.
    Pedersen BK; Bygbjerg IC; Theander TG; Andersen BJ
    Allergy; 1986 Sep; 41(7):537-42. PubMed ID: 2431633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autologous mechanisms generating natural killer activity within human peripheral lymphocytes depleted of NK target-binding cells.
    Whisler RL; Bakenhaster K; Opremcak EM
    Cell Immunol; 1982 Jan; 66(2):342-51. PubMed ID: 6175429
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of interferon in the NK cell killing of virus-infected target cells.
    Anderson MJ
    J Hyg (Lond); 1982 Oct; 89(2):347-51. PubMed ID: 6182244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of NK, but not K cell activity by different interferons.
    Rumpold H; Kraft D; Scheiner O; Meindl P; Bodo G
    Int Arch Allergy Appl Immunol; 1980; 62(2):152-61. PubMed ID: 6154652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of various interferons on the spontaneous cytotoxicity exerted by lymphocytes from normal and tumor-bearing patients.
    Lucero MA; Fridman WH; Provost MA; Billardon C; Pouillart P; Dumont J; Falcoff E
    Cancer Res; 1981 Jan; 41(1):294-9. PubMed ID: 6160906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic administration of human leukocyte interferon to melanoma patients. II. Cellular events associated with changes in natural killer cytotoxicity.
    Golub SH; D'Amore P; Rainey M
    J Natl Cancer Inst; 1982 May; 68(5):711-7. PubMed ID: 6175788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Locus of selective depression of human natural killer cells by azathioprine.
    Shih WW; Ellison GW; Myers LW; Durkos-Smith D; Fahey JL
    Clin Immunol Immunopathol; 1982 Jun; 23(3):672-81. PubMed ID: 6180857
    [No Abstract]   [Full Text] [Related]  

  • 19. Natural killing activity and interferon production in multiple sclerosis.
    Zander H; Abb J; Kaudewitz P; Riethmüller G
    Lancet; 1982 Jan; 1(8266):280. PubMed ID: 6173558
    [No Abstract]   [Full Text] [Related]  

  • 20. Enriched natural killing and antibody-dependent cellular cytotoxicity in lymphocyte populations adherent to tumor cell monolayers.
    Jensen PJ; Koren HS
    Immunobiology; 1982 May; 161(5):494-506. PubMed ID: 6178680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.